Effect of RIPK3 on non-canonical PANoptosis to suppress anti-tumor immunity in lung cancer.

被引:0
|
作者
Zhong, Hua [1 ]
Yang, Yv [1 ]
Wang, Yue [1 ]
Wu, Erpeng [1 ]
机构
[1] Shanghai Chest Hosp, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14565
引用
收藏
页数:1
相关论文
共 50 条
  • [1] RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment
    Han-Hee Park
    Hwa-Ryeon Kim
    Sang-Yeong Park
    Sung-Min Hwang
    Sun Mi Hong
    Sangwook Park
    Ho Chul Kang
    Michael J. Morgan
    Jong-Ho Cha
    Dakeun Lee
    Jae-Seok Roe
    You-Sun Kim
    Molecular Cancer, 20
  • [2] RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment
    Park, Han-Hee
    Kim, Hwa-Ryeon
    Park, Sang-Yeong
    Hwang, Sung-Min
    Hong, Sun Mi
    Park, Sangwook
    Kang, Ho Chul
    Morgan, Michael J.
    Cha, Jong-Ho
    Lee, Dakeun
    Roe, Jae-Seok
    Kim, You-Sun
    MOLECULAR CANCER, 2021, 20 (01)
  • [3] Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer
    Luo, Lianxiang
    Wu, Tong
    Ji, Miaorong
    Xiang, Jing
    Zou, Youwen
    Liao, Yinglin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [4] Prognostic Significance of CHIP and RIPK3 in Non-Small Cell Lung Cancer
    Kim, Jisup
    Chung, Joon-Yong
    Park, Young Soo
    Jang, Se Jin
    Kim, Hyeong Ryul
    Choi, Chang-Min
    Song, Joon Seon
    CANCERS, 2020, 12 (06) : 1 - 13
  • [5] RIPK3 downregulation in lung cancer alters the tumor immune micro-environment supporting tumor progression
    Allmendinger, F.
    Agrawal, D.
    Dietzen, M.
    Vosberg, S.
    Munkhbaatar, E.
    Branca, C.
    McGranahan, N.
    Jost, P. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 51 - 52
  • [6] THC-mediated, IL-10-dependent suppression of anti-tumor immunity of murine lung cancer.
    Zhu, L
    Sharma, S
    Stolina, M
    Gardner, B
    Roth, M
    Tashkin, D
    Dubinett, SM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A404 - A404
  • [7] Anti-tumor immunity is a key determinant of small cell lung cancer survivorship
    Kosari, Farhad
    Muppa, Prasuna
    Terra, Simone
    Sharma, Anurag
    Mansfield, Aaron
    Aubry, Marie Christine
    Janaki, Nafiseh
    Nasir, Aqsa
    Peikert, Tobias
    CANCER RESEARCH, 2019, 79 (13)
  • [8] TELOMERE DYSFUNCTION MEDIATES ANTI-TUMOR IMMUNITY IN SMALL CELL LUNG CANCER
    Zhu, Mingrui
    Eglenen-Polat, Buse
    Bender, Matthew
    Mender, Ilgen
    Siteni, Silvia
    Drapkin, Benjamin
    Shay, Jerry
    Akbay, Esra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A944 - A944
  • [9] The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer
    Szczepny, A.
    Rogers, S.
    Jayasekara, W. S. N.
    Park, K.
    McCloy, R. A.
    Cochrane, C. R.
    Ganju, V.
    Cooper, W. A.
    Sage, J.
    Peacock, C. D.
    Cain, J. E.
    Burgess, A.
    Watkins, D. N.
    ONCOGENE, 2017, 36 (39) : 5544 - 5550
  • [10] The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer
    A Szczepny
    S Rogers
    W S N Jayasekara
    K Park
    R A McCloy
    C R Cochrane
    V Ganju
    W A Cooper
    J Sage
    C D Peacock
    J E Cain
    A Burgess
    D N Watkins
    Oncogene, 2017, 36 : 5544 - 5550